Found: 31
Select item for more details and to access through your institution.
Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
- Published in:
- Allergy & Asthma Proceedings, 2014, v. 35, n. 1, p. 54, doi. 10.2500/aap.2014.35.3720
- By:
- Publication type:
- Article
Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.
- Published in:
- Allergy & Asthma Proceedings, 2010, v. 31, n. 3, p. 203, doi. 10.2500/aap.2010.31.3359
- By:
- Publication type:
- Article
Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.
- Published in:
- Allergy & Asthma Proceedings, 2010, v. 31, n. 3, p. 211, doi. 10.2500/aap.2010.31.3360
- By:
- Publication type:
- Article
Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost-Effectiveness of Zoledronic Acid Plus Endocrine Therapy in Premenopausal Women With Hormone-Responsive Early Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 4, p. 267, doi. 10.3816/CBC.2010.n.034
- By:
- Publication type:
- Article
Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2-Advanced Breast Cancer.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 491, doi. 10.3390/curroncol28010051
- By:
- Publication type:
- Article
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.
- Published in:
- American Journal of Health-System Pharmacy, 2007, v. 64, n. 11, p. 1187, doi. 10.2146/ajhp060380
- By:
- Publication type:
- Article
The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom.
- Published in:
- Sarcoma, 2014, p. 1, doi. 10.1155/2014/481071
- By:
- Publication type:
- Article
Valsartan versus lisinopril or metoprolol to prevent cardiovascular events in patients with hypertension
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor- and HER2-Positive Metastatic Breast Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 1, p. 103, doi. 10.1007/s00520-013-1951-z
- By:
- Publication type:
- Article
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Survival Outcomes in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Receiving Third- or Subsequent Line (3L) Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S311, doi. 10.1016/j.clml.2017.07.111
- By:
- Publication type:
- Article
Lifetime Costs for Treated Follicular Lymphoma Patients in the US.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 10, p. 1163, doi. 10.1007/s40273-021-01052-3
- By:
- Publication type:
- Article
Cost Effectiveness of Ribociclib in Combination with Fulvestrant for the Treatment of Postmenopausal Women with HR+/HER2− Advanced Breast Cancer Who Have Received No or Only One Prior Line of Endocrine Therapy: A Canadian Healthcare Perspective.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 9, p. 1045, doi. 10.1007/s40273-021-01027-4
- By:
- Publication type:
- Article
Cost Effectiveness of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Pre-/Perimenopausal, HR+ and HER2- Advanced Breast Cancer: A Canadian Healthcare Perspective.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
- Published in:
- Transfusion, 2007, v. 47, n. 10, p. 1919, doi. 10.1111/j.1537-2995.2007.01416.x
- By:
- Publication type:
- Article
Association Between Use of Thiazolidinediones and Costs of Heart Failure in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A317
- By:
- Publication type:
- Article
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 4, p. 263, doi. 10.1002/ajh.21049
- By:
- Publication type:
- Article
Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8179, doi. 10.2147/CMAR.S325043
- By:
- Publication type:
- Article
Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover - The Case of Pazopanib in Advanced Renal Cell Carcinoma.
- Published in:
- Oncology, 2016, v. 90, n. 3, p. 119, doi. 10.1159/000443647
- By:
- Publication type:
- Article
Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia.
- Published in:
- Cost Effectiveness & Resource Allocation, 2017, v. 15, p. 1, doi. 10.1186/s12962-017-0071-x
- By:
- Publication type:
- Article
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 565, doi. 10.1007/s40487-024-00291-6
- By:
- Publication type:
- Article
Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0175920
- By:
- Publication type:
- Article
Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0175721
- By:
- Publication type:
- Article